OrbiMed Advisors LLC and affiliated entities
Filed with the SEC on · accession 0000947871-26-000813
BLSM filed a SCHEDULE 13D (schedule 13d) with the SEC on Aug 18, 2026. OrbiMed Advisors LLC and affiliated entities filed a joint Schedule 13D regarding their ownership of common stock in BlossomHill Therapeutics, Inc., dated August 10, 2026. The stock moved -1.7% by the first close after the filing.
OrbiMed Advisors LLC and affiliated entities filed a joint Schedule 13D regarding their ownership of common stock in BlossomHill Therapeutics, Inc., dated August 10, 2026. The filing indicates an active ownership position by the OrbiMed entities.
Close before
$16.38
Aug 17, 2026
First close after
-1.71%
$16.10
5 trading days
-2.14%
$16.03
Since filing
-17.58%
$13.50
✦ Ask GOAX AI about this filing — what it means for BLSM, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for BLSM?
Click hereBLSM filed a SCHEDULE 13D (SEC filing). OrbiMed Advisors LLC and affiliated entities filed a joint Schedule 13D regarding their ownership of common stock in BlossomHill Therapeutics, Inc., dated August 10, 2026. The filing indicates an active ownership position by the OrbiMed entities.
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D (schedule 13d): A report the company filed with the SEC (the US market regulator).
BLSM closed at $16.38 before the filing and $16.10 on Aug 18, 2026 (-1.71%). Five trading days later: $16.03 (-2.14%).
Get alerts when BLSM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days